Literature DB >> 16805771

Glycine receptors: recent insights into their structural organization and functional diversity.

Heinrich Betz1, Bodo Laube.   

Abstract

Strychnine-sensitive glycine receptors (GlyRs) are known to mediate synaptic inhibition in spinal cord, brainstem and other regions of the CNS. During the past 5 years, considerable progress has been made in delineating structural determinants of ligand binding and channel activation in recombinant GlyRs. Furthermore, immunohistochemical and gene inactivation studies have disclosed distinct distributions and functions of differentially expressed GlyR subtypes in retina, hippocampus and the dorsal horn of the spinal cord. Accordingly, GlyRs regulate not only the excitability of motor and sensory neurones, but are also essential for the processing of photoreceptor signals, neuronal development and inflammatory pain sensitization. Hence, these receptors constitute promising targets for the development of clinically useful compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805771     DOI: 10.1111/j.1471-4159.2006.03908.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  92 in total

1.  Allosteric potentiation of glycine receptor chloride currents by glutamate.

Authors:  Jun Liu; Dong Chuan Wu; Yu Tian Wang
Journal:  Nat Neurosci       Date:  2010-09-12       Impact factor: 24.884

2.  A crosstalk between β1 and β3 integrins controls glycine receptor and gephyrin trafficking at synapses.

Authors:  Cécile Charrier; Patricia Machado; Ry Y Tweedie-Cullen; Dorothea Rutishauser; Isabelle M Mansuy; Antoine Triller
Journal:  Nat Neurosci       Date:  2010-10-10       Impact factor: 24.884

3.  Subunit stoichiometry and arrangement in a heteromeric glutamate-gated chloride channel.

Authors:  Nurit Degani-Katzav; Revital Gortler; Lilach Gorodetzki; Yoav Paas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

4.  Propofol modulation of α1 glycine receptors does not require a structural transition at adjacent subunits that is crucial to agonist-induced activation.

Authors:  Timothy Lynagh; Alexander Kunz; Bodo Laube
Journal:  ACS Chem Neurosci       Date:  2013-09-17       Impact factor: 4.418

5.  Open-channel structures of the human glycine receptor α1 full-length transmembrane domain.

Authors:  David D Mowrey; Tanxing Cui; Yuanyuan Jia; Dejian Ma; Alexander M Makhov; Peijun Zhang; Pei Tang; Yan Xu
Journal:  Structure       Date:  2013-08-29       Impact factor: 5.006

6.  Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.

Authors:  Nilufar Foadi; Martin Leuwer; Reyhan Demir; Reinhard Dengler; Vanessa Buchholz; Jeanne de la Roche; Matthias Karst; Gertrud Haeseler; Jörg Ahrens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-26       Impact factor: 3.000

7.  Expression of glycine receptors and gephyrin in the rat cochlea.

Authors:  Julia Dlugaiczyk; Wibke Singer; Bernhard Schick; Heinrich Iro; Kristina Becker; Cord-Michael Becker; Ulrike Zimmermann; Karin Rohbock; Marlies Knipper
Journal:  Histochem Cell Biol       Date:  2008-01-30       Impact factor: 4.304

Review 8.  Molecular architecture of glycinergic synapses.

Authors:  Thomas Dresbach; Ralph Nawrotzki; Thomas Kremer; Stefanie Schumacher; Daniel Quinones; Martin Kluska; Jochen Kuhse; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2008-08-22       Impact factor: 4.304

9.  In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T.

Authors:  Giulio Gambarota; Ralf Mekle; Lijing Xin; Martin Hergt; Wietske van der Zwaag; Gunnar Krueger; Rolf Gruetter
Journal:  MAGMA       Date:  2008-10-24       Impact factor: 2.310

10.  Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.

Authors:  Wei Xiong; Shao-Rui Chen; Liming He; Kejun Cheng; Yi-Lin Zhao; Hong Chen; De-Pei Li; Gregg E Homanics; John Peever; Kenner C Rice; Ling-gang Wu; Hui-Lin Pan; Li Zhang
Journal:  Nat Neurosci       Date:  2014-01-05       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.